PAREXEL's ClinPhone RTSM Cuts Clinical Trial Start-Up Time

Zacks Equity Research

Wed, Jun 18, 2014, 5:35 PM

Global biopharmaceutical services organization, PAREXEL International Corporation (PRXL) launched a new version of its industry standard ClinPhone RTSM (Randomization and Trial Supply Management) solution designed to help start clinical trials more quickly. Following the announcement, shares of PAREXEL climbed 2.2% to close at $53.67 yesterday.

The latest version of the ClinPhone RTSM solution has been developed by PAREXEL Informatics – PAREXEL's wholly owned technology subsidiary, which acquired ClinPhone Plc – a clinical technology organization, in 2008.

At the start of a clinical trial, clients have to simultaneously initiate a broad range of important activities such as patient screening, enrollment and randomization, drug dispensation and supply distribution. PAREXEL’s ClinPhone RTSM is incorporated with flexible, pre-built and interactive web modules that allow rapid implementation of patient, supplies and site management activities.

As part of the ClinPhone RTSM solution, its web modules provide extended functionality and place increased administrative and management control in the hands of the study teams. Integrated with the latest RTSM technology that features standardized study components for faster implementation and greater design flexibility, the study teams can start their trials more quickly.

RTSM solution is a key component of PAREXEL’s proprietary Perceptive MyTrials platform, an integrated suite of applications for managing clinical trials. The leading edge solution has been used in more than 3,000 studies involving over 400,000 sites and two million patients since 1993.

PAREXEL’s ClinPhone RTSM is available as a standalone solution as well as through the Perceptive MyTrials platform. ClinPhone RTSM and the Perceptive MyTrials platform are also available through the company’s Perceptive Partner Program.

PAREXEL intends to meet the increasing need for conducting faster and more efficient trials by making considerable investments in developing cutting-edge technology. It is also focusing on making drug development more efficient, without compromising on patient safety or data quality.

Currently, PAREXEL has a Zacks Rank #3 (Hold). Better-ranked stocks in the medical services industry include ICON Public Limited Company (ICLR), BG Medicine, Inc. (BGMD) and Omnicare Inc. (OCR). While ICON Public Limited Company sports a Zacks Rank #1 (Strong Buy), both BG Medicine and Omnicare carry a Zacks Rank #2 (Buy).

Read the Full Research Report on OCR
Read the Full Research Report on PRXL
Read the Full Research Report on ICLR
Read the Full Research Report on BGMD

Zacks Investment Research

Homes are overvalued in much of the U.S. — with these 5 states leading the list
Home prices are overvalued nationally, according to a new report by Fitch Ratings, led by Southern states.
MarketWatch
The $1.7 Billion News That Sent Plug Power Stock Surging: Here's What You Need to Know Before Buying
More cash will solve some problems, but maybe not the ones that need to be solved.
Motley Fool
Warren Buffett "Guaranteed" He'd Get 50% Annual Returns With Only $1 Million As Berkshire's Cash Hoard Soars To Over $189 Billion
Legendary investor Warren Buffett has long advocated for the average investor to regularly put money in an S&P 500 index fund rather than buying actively managed funds. However, that's not to say he doesn't think massive outperformance isn't possible. As far back as 1999, Mr. Buffett famously said he could achieve 50% annual returns if he had only $1 million to manage, stating, "The highest rates of return I’ve ever achieved were in the 1950s. I killed the Dow. You ought to see the numbers. But
Benzinga
JPMorgan's trading desk lays out 6 scenarios for tomorrow's inflation report, and how the stock market will react to each of them
The S&P 500 could soar nearly 3% to record highs or experience a deep plunge depending on where tomorrow's CPI inflation report falls, JPMorgan says.
Business Insider
Analyst reboots Palo Alto Network stock price target ahead of earnings
This is what could happen next to Palo Alto Network shares.
TheStreet
Billionaire Bill Gates Has 67% of His $42 Billion Portfolio in These 3 Stocks
The billionaire investor has made sage investment decisions to safeguard his portfolio from economic uncertainties.
Motley Fool
'Which Bucket Do I Draw From First?' Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts
When Ellen, a 67-year-old retiree, reached out to Suze Orman during her podcast, she had a straightforward yet crucial financial inquiry: "Which bucket do I draw from first?" Ellen, whose Social Security covers most of her daily living expenses, needed guidance on how to use her different types of retirement accounts for additional expenditures like travel. Don't Miss: The recommended retirement savings amount is $550K, but here is why so many Americans are falling short. Reddit user reveals his
Benzinga
Is There Actually an RMD Cut-Off Age?
Required minimum distributions (RMDs) are the minimum amount that you must withdraw from certain tax-advantaged retirement accounts. They begin at age 72 or 73, depending on your circumstances and continue indefinitely. There is, unfortunately, no age when RMDs stop. You … Continue reading → The post At What Age Do RMDs Stop? appeared first on SmartAsset Blog.
SmartAsset
My father ‘deliberately and hurtfully’ cut my late sister’s two kids out of his will. How can I ensure they get their fair share?
“How can I best do this in such a way that nobody is penalized from gift taxes and other costs?”
MarketWatch
Morning Bid: Power of Powell lifts stocks ahead of US CPI
European bourses are poised to keep the rally going ahead of the always important U.S. CPI data after comments from Fed Chair Jerome Powell reassured investors that the next move from the U.S. central bank was unlikely to be a hike. Powell called Tuesday's higher-than-expected producer price report 'mixed' rather than 'hot' because prior data was revised lower. Though Powell's comments largely restated those made at his press conference after the Fed's last meeting, it was enough for stocks to surge, with Asian shares at their highest in 15 months and Nasdaq closing at a record high.
Reuters

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

PAREXEL's ClinPhone RTSM Cuts Clinical Trial Start-Up Time

Recommended Stories

Homes are overvalued in much of the U.S. — with these 5 states leading the list

The $1.7 Billion News That Sent Plug Power Stock Surging: Here's What You Need to Know Before Buying

Warren Buffett "Guaranteed" He'd Get 50% Annual Returns With Only $1 Million As Berkshire's Cash Hoard Soars To Over $189 Billion

JPMorgan's trading desk lays out 6 scenarios for tomorrow's inflation report, and how the stock market will react to each of them

Analyst reboots Palo Alto Network stock price target ahead of earnings

Billionaire Bill Gates Has 67% of His $42 Billion Portfolio in These 3 Stocks

'Which Bucket Do I Draw From First?' Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts

Is There Actually an RMD Cut-Off Age?

My father ‘deliberately and hurtfully’ cut my late sister’s two kids out of his will. How can I ensure they get their fair share?

Morning Bid: Power of Powell lifts stocks ahead of US CPI